APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-inflammatory Drugs for Dental

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Anti-inflammatory Drugs for Dental Market Outlook and Growth Opportunities 2026

27 December 2025207 pages

Choose your research edition.

Industry ResearchAnti-inflammatory Drugs for Dental Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-inflammatory Drugs for Dental Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Anti-inflammatory Drugs for Dental Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-inflammatory Drugs for Dental Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-inflammatory Drugs for Dental Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Anti-inflammatory Drugs for Dental market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Anti-inflammatory Drugs for Dental is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anti-inflammatory Drugs for Dental is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-inflammatory Drugs for Dental is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Anti-inflammatory Drugs for Dental market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Anti-inflammatory Drugs for Dental market include Xiuzheng Pharmaceutical, Merck, Roche, Hutchison China MediTech, Bayer, Xttrium Laboratorie, Sunstar, Showa Yakuhin Kako and Septodont, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Anti-inflammatory Drugs for Dental market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anti-inflammatory Drugs for Dental and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anti-inflammatory Drugs for Dental revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Anti-inflammatory Drugs for Dental market.

Anti-inflammatory Drugs for Dental Segment by Company

Xiuzheng Pharmaceutical

Merck

Roche

Hutchison China MediTech

Bayer

Xttrium Laboratorie

Sunstar

Showa Yakuhin Kako

Septodont

PerioChip

Mediwin Pharmaceuticals

JandJ

GSK

DenMat

Colgate-Palmolive

Bausch Health

Acteon

3M

Anti-inflammatory Drugs for Dental Segment by Type

OTC

Prescription

Anti-inflammatory Drugs for Dental Segment by Application

Dental Clinics

Hospitals

Pharmacies

Anti-inflammatory Drugs for Dental Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Anti-inflammatory Drugs for Dental status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Anti-inflammatory Drugs for Dental key companies, revenue, market share, and recent developments.

3. To split the Anti-inflammatory Drugs for Dental breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Anti-inflammatory Drugs for Dental market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Anti-inflammatory Drugs for Dental significant trends, drivers, influence factors in global and regions.

6. To analyze Anti-inflammatory Drugs for Dental competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-inflammatory Drugs for Dental market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-inflammatory Drugs for Dental and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-inflammatory Drugs for Dental.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Anti-inflammatory Drugs for Dental industry.

Chapter 3: Detailed analysis of Anti-inflammatory Drugs for Dental company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Anti-inflammatory Drugs for Dental in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Anti-inflammatory Drugs for Dental in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Anti-inflammatory Drugs for Dental Industry Trends Table 2. Anti-inflammatory Drugs for Dental Industry Drivers Table 3. Anti-inflammatory Drugs for Dental Industry Opportunities and Challenges Table 4. Anti-inflammatory Drugs for Dental Industry Restraints Table 5. Global Anti-inflammatory Drugs for Dental Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Anti-inflammatory Drugs for Dental Revenue Share by Company (2021-2026) Table 7. Global Anti-inflammatory Drugs for Dental Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Anti-inflammatory Drugs for Dental Key Company Manufacturing Base & Headquarters Table 9. Global Anti-inflammatory Drugs for Dental Company, Product Type & Application Table 10. Global Anti-inflammatory Drugs for Dental Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Anti-inflammatory Drugs for Dental by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of OTC Table 15. Significant Companies of Prescription Table 16. Global Anti-inflammatory Drugs for Dental Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Anti-inflammatory Drugs for Dental Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Anti-inflammatory Drugs for Dental Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Anti-inflammatory Drugs for Dental Sales Value Share by Type (2021-2026) Table 20. Global Anti-inflammatory Drugs for Dental Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Dental Clinics Table 22. Significant Companies of Hospitals Table 23. Significant Companies of Pharmacies Table 24. Global Anti-inflammatory Drugs for Dental Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Anti-inflammatory Drugs for Dental Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Anti-inflammatory Drugs for Dental Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Anti-inflammatory Drugs for Dental Sales Value Share by Application (2021-2026) Table 28. Global Anti-inflammatory Drugs for Dental Sales Value Share by Application (2027-2032) Table 29. Global Anti-inflammatory Drugs for Dental Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Anti-inflammatory Drugs for Dental Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Anti-inflammatory Drugs for Dental Sales Value Share by Region (2021-2026) Table 32. Global Anti-inflammatory Drugs for Dental Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Anti-inflammatory Drugs for Dental Sales Value Share by Region (2027-2032) Table 34. Global Anti-inflammatory Drugs for Dental Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Anti-inflammatory Drugs for Dental Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Anti-inflammatory Drugs for Dental Sales Value Market Share by Country (2021-2026) Table 37. Global Anti-inflammatory Drugs for Dental Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Anti-inflammatory Drugs for Dental Sales Value Market Share by Country (2027-2032) Table 39. Xiuzheng Pharmaceutical Company Information Table 40. Xiuzheng Pharmaceutical Business Overview Table 41. Xiuzheng Pharmaceutical Anti-inflammatory Drugs for Dental Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Xiuzheng Pharmaceutical Anti-inflammatory Drugs for Dental Product Portfolio Table 43. Xiuzheng Pharmaceutical Recent Development Table 44. Merck Company Information Table 45. Merck Business Overview Table 46. Merck Anti-inflammatory Drugs for Dental Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Merck Anti-inflammatory Drugs for Dental Product Portfolio Table 48. Merck Recent Development Table 49. Roche Company Information Table 50. Roche Business Overview Table 51. Roche Anti-inflammatory Drugs for Dental Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Roche Anti-inflammatory Drugs for Dental Product Portfolio Table 53. Roche Recent Development Table 54. Hutchison China MediTech Company Information Table 55. Hutchison China MediTech Business Overview Table 56. Hutchison China MediTech Anti-inflammatory Drugs for Dental Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Hutchison China MediTech Anti-inflammatory Drugs for Dental Product Portfolio Table 58. Hutchison China MediTech Recent Development Table 59. Bayer Company Information Table 60. Bayer Business Overview Table 61. Bayer Anti-inflammatory Drugs for Dental Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Bayer Anti-inflammatory Drugs for Dental Product Portfolio Table 63. Bayer Recent Development Table 64. Xttrium Laboratorie Company Information Table 65. Xttrium Laboratorie Business Overview Table 66. Xttrium Laboratorie Anti-inflammatory Drugs for Dental Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Xttrium Laboratorie Anti-inflammatory Drugs for Dental Product Portfolio Table 68. Xttrium Laboratorie Recent Development Table 69. Sunstar Company Information Table 70. Sunstar Business Overview Table 71. Sunstar Anti-inflammatory Drugs for Dental Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Sunstar Anti-inflammatory Drugs for Dental Product Portfolio Table 73. Sunstar Recent Development Table 74. Showa Yakuhin Kako Company Information Table 75. Showa Yakuhin Kako Business Overview Table 76. Showa Yakuhin Kako Anti-inflammatory Drugs for Dental Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Showa Yakuhin Kako Anti-inflammatory Drugs for Dental Product Portfolio Table 78. Showa Yakuhin Kako Recent Development Table 79. Septodont Company Information Table 80. Septodont Business Overview Table 81. Septodont Anti-inflammatory Drugs for Dental Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Septodont Anti-inflammatory Drugs for Dental Product Portfolio Table 83. Septodont Recent Development Table 84. PerioChip Company Information Table 85. PerioChip Business Overview Table 86. PerioChip Anti-inflammatory Drugs for Dental Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. PerioChip Anti-inflammatory Drugs for Dental Product Portfolio Table 88. PerioChip Recent Development Table 89. Mediwin Pharmaceuticals Company Information Table 90. Mediwin Pharmaceuticals Business Overview Table 91. Mediwin Pharmaceuticals Anti-inflammatory Drugs for Dental Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Mediwin Pharmaceuticals Anti-inflammatory Drugs for Dental Product Portfolio Table 93. Mediwin Pharmaceuticals Recent Development Table 94. JandJ Company Information Table 95. JandJ Business Overview Table 96. JandJ Anti-inflammatory Drugs for Dental Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. JandJ Anti-inflammatory Drugs for Dental Product Portfolio Table 98. JandJ Recent Development Table 99. GSK Company Information Table 100. GSK Business Overview Table 101. GSK Anti-inflammatory Drugs for Dental Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. GSK Anti-inflammatory Drugs for Dental Product Portfolio Table 103. GSK Recent Development Table 104. DenMat Company Information Table 105. DenMat Business Overview Table 106. DenMat Anti-inflammatory Drugs for Dental Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. DenMat Anti-inflammatory Drugs for Dental Product Portfolio Table 108. DenMat Recent Development Table 109. Colgate-Palmolive Company Information Table 110. Colgate-Palmolive Business Overview Table 111. Colgate-Palmolive Anti-inflammatory Drugs for Dental Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Colgate-Palmolive Anti-inflammatory Drugs for Dental Product Portfolio Table 113. Colgate-Palmolive Recent Development Table 114. Bausch Health Company Information Table 115. Bausch Health Business Overview Table 116. Bausch Health Anti-inflammatory Drugs for Dental Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Bausch Health Anti-inflammatory Drugs for Dental Product Portfolio Table 118. Bausch Health Recent Development Table 119. Acteon Company Information Table 120. Acteon Business Overview Table 121. Acteon Anti-inflammatory Drugs for Dental Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Acteon Anti-inflammatory Drugs for Dental Product Portfolio Table 123. Acteon Recent Development Table 124. 3M Company Information Table 125. 3M Business Overview Table 126. 3M Anti-inflammatory Drugs for Dental Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. 3M Anti-inflammatory Drugs for Dental Product Portfolio Table 128. 3M Recent Development Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Anti-inflammatory Drugs for Dental Product Image Figure 2. Global Anti-inflammatory Drugs for Dental Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-inflammatory Drugs for Dental Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-inflammatory Drugs for Dental Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. OTC Image Figure 8. Prescription Image Figure 9. Global Anti-inflammatory Drugs for Dental Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Anti-inflammatory Drugs for Dental Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Anti-inflammatory Drugs for Dental Sales Value Share by Type (2021-2032) Figure 12. Dental Clinics Image Figure 13. Hospitals Image Figure 14. Pharmacies Image Figure 15. Global Anti-inflammatory Drugs for Dental Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Anti-inflammatory Drugs for Dental Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Anti-inflammatory Drugs for Dental Sales Value Share by Application (2021-2032) Figure 18. Global Anti-inflammatory Drugs for Dental Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Anti-inflammatory Drugs for Dental Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Anti-inflammatory Drugs for Dental Sales Value (2021-2032) & (US$ Million) Figure 21. North America Anti-inflammatory Drugs for Dental Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Anti-inflammatory Drugs for Dental Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Anti-inflammatory Drugs for Dental Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Anti-inflammatory Drugs for Dental Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Anti-inflammatory Drugs for Dental Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Anti-inflammatory Drugs for Dental Sales Value (2021-2032) & (US$ Million) Figure 27. South America Anti-inflammatory Drugs for Dental Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Anti-inflammatory Drugs for Dental Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Anti-inflammatory Drugs for Dental Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • OTC
  • Prescription
Applications
  • Dental Clinics
  • Hospitals
  • Pharmacies
Companies covered
  • Xiuzheng Pharmaceutical
  • Merck
  • Roche
  • Hutchison China MediTech
  • Bayer
  • Xttrium Laboratorie
  • Sunstar
  • Showa Yakuhin Kako
  • Septodont
  • PerioChip
  • Mediwin Pharmaceuticals
  • JandJ
  • GSK
  • DenMat
  • Colgate-Palmolive
  • Bausch Health
  • Acteon
  • 3M

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Anti-inflammatory Drugs for Dental Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Anti-inflammatory Drugs for Dental Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Anti-inflammatory Drugs for Dental Market Dynamics
  1. 2.1 Anti-inflammatory Drugs for Dental Industry Trends
  2. 2.2 Anti-inflammatory Drugs for Dental Industry Drivers
  3. 2.3 Anti-inflammatory Drugs for Dental Industry Opportunities and Challenges
  4. 2.4 Anti-inflammatory Drugs for Dental Industry Restraints
3 Anti-inflammatory Drugs for Dental Market by Company
  1. 3.1 Global Anti-inflammatory Drugs for Dental Company Revenue Ranking in 2025
  2. 3.2 Global Anti-inflammatory Drugs for Dental Revenue by Company (2021-2026)
  3. 3.3 Global Anti-inflammatory Drugs for Dental Company Ranking (2024-2026)
  4. 3.4 Global Anti-inflammatory Drugs for Dental Company Manufacturing Base and Headquarters
  5. 3.5 Global Anti-inflammatory Drugs for Dental Company Product Type and Application
  6. 3.6 Global Anti-inflammatory Drugs for Dental Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Anti-inflammatory Drugs for Dental Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Anti-inflammatory Drugs for Dental Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Anti-inflammatory Drugs for Dental Market by Type
  1. 4.1 Anti-inflammatory Drugs for Dental Type Introduction
  2. 4.1.1 OTC
  3. 4.1.2 Prescription
  4. 4.2 Global Anti-inflammatory Drugs for Dental Sales Value by Type
  5. 4.2.1 Global Anti-inflammatory Drugs for Dental Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Anti-inflammatory Drugs for Dental Sales Value by Type (2021-2032)
  7. 4.2.3 Global Anti-inflammatory Drugs for Dental Sales Value Share by Type (2021-2032)
5 Anti-inflammatory Drugs for Dental Market by Application
  1. 5.1 Anti-inflammatory Drugs for Dental Application Introduction
  2. 5.1.1 Dental Clinics
  3. 5.1.2 Hospitals
  4. 5.1.3 Pharmacies
  5. 5.2 Global Anti-inflammatory Drugs for Dental Sales Value by Application
  6. 5.2.1 Global Anti-inflammatory Drugs for Dental Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Anti-inflammatory Drugs for Dental Sales Value by Application (2021-2032)
  8. 5.2.3 Global Anti-inflammatory Drugs for Dental Sales Value Share by Application (2021-2032)
6 Anti-inflammatory Drugs for Dental Regional Value Analysis
  1. 6.1 Global Anti-inflammatory Drugs for Dental Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Anti-inflammatory Drugs for Dental Sales Value by Region (2021-2032)
  3. 6.2.1 Global Anti-inflammatory Drugs for Dental Sales Value by Region: 2021-2026
  4. 6.2.2 Global Anti-inflammatory Drugs for Dental Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Anti-inflammatory Drugs for Dental Sales Value (2021-2032)
  7. 6.3.2 North America Anti-inflammatory Drugs for Dental Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Anti-inflammatory Drugs for Dental Sales Value (2021-2032)
  10. 6.4.2 Europe Anti-inflammatory Drugs for Dental Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Anti-inflammatory Drugs for Dental Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Anti-inflammatory Drugs for Dental Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Anti-inflammatory Drugs for Dental Sales Value (2021-2032)
  16. 6.6.2 South America Anti-inflammatory Drugs for Dental Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Anti-inflammatory Drugs for Dental Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Anti-inflammatory Drugs for Dental Sales Value Share by Country, 2025 VS 2032
7 Anti-inflammatory Drugs for Dental Country-level Value Analysis
  1. 7.1 Global Anti-inflammatory Drugs for Dental Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Anti-inflammatory Drugs for Dental Sales Value by Country (2021-2032)
  3. 7.2.1 Global Anti-inflammatory Drugs for Dental Sales Value by Country (2021-2026)
  4. 7.2.2 Global Anti-inflammatory Drugs for Dental Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Anti-inflammatory Drugs for Dental Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Anti-inflammatory Drugs for Dental Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Anti-inflammatory Drugs for Dental Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Xiuzheng Pharmaceutical
  2. 8.1.1 Xiuzheng Pharmaceutical Company Information
  3. 8.1.2 Xiuzheng Pharmaceutical Business Overview
  4. 8.1.3 Xiuzheng Pharmaceutical Anti-inflammatory Drugs for Dental Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Xiuzheng Pharmaceutical Anti-inflammatory Drugs for Dental Product Portfolio
  6. 8.1.5 Xiuzheng Pharmaceutical Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Anti-inflammatory Drugs for Dental Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck Anti-inflammatory Drugs for Dental Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Roche
  14. 8.3.1 Roche Company Information
  15. 8.3.2 Roche Business Overview
  16. 8.3.3 Roche Anti-inflammatory Drugs for Dental Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Roche Anti-inflammatory Drugs for Dental Product Portfolio
  18. 8.3.5 Roche Recent Developments
  19. 8.4 Hutchison China MediTech
  20. 8.4.1 Hutchison China MediTech Company Information
  21. 8.4.2 Hutchison China MediTech Business Overview
  22. 8.4.3 Hutchison China MediTech Anti-inflammatory Drugs for Dental Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hutchison China MediTech Anti-inflammatory Drugs for Dental Product Portfolio
  24. 8.4.5 Hutchison China MediTech Recent Developments
  25. 8.5 Bayer
  26. 8.5.1 Bayer Company Information
  27. 8.5.2 Bayer Business Overview
  28. 8.5.3 Bayer Anti-inflammatory Drugs for Dental Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bayer Anti-inflammatory Drugs for Dental Product Portfolio
  30. 8.5.5 Bayer Recent Developments
  31. 8.6 Xttrium Laboratorie
  32. 8.6.1 Xttrium Laboratorie Company Information
  33. 8.6.2 Xttrium Laboratorie Business Overview
  34. 8.6.3 Xttrium Laboratorie Anti-inflammatory Drugs for Dental Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Xttrium Laboratorie Anti-inflammatory Drugs for Dental Product Portfolio
  36. 8.6.5 Xttrium Laboratorie Recent Developments
  37. 8.7 Sunstar
  38. 8.7.1 Sunstar Company Information
  39. 8.7.2 Sunstar Business Overview
  40. 8.7.3 Sunstar Anti-inflammatory Drugs for Dental Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sunstar Anti-inflammatory Drugs for Dental Product Portfolio
  42. 8.7.5 Sunstar Recent Developments
  43. 8.8 Showa Yakuhin Kako
  44. 8.8.1 Showa Yakuhin Kako Company Information
  45. 8.8.2 Showa Yakuhin Kako Business Overview
  46. 8.8.3 Showa Yakuhin Kako Anti-inflammatory Drugs for Dental Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Showa Yakuhin Kako Anti-inflammatory Drugs for Dental Product Portfolio
  48. 8.8.5 Showa Yakuhin Kako Recent Developments
  49. 8.9 Septodont
  50. 8.9.1 Septodont Company Information
  51. 8.9.2 Septodont Business Overview
  52. 8.9.3 Septodont Anti-inflammatory Drugs for Dental Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Septodont Anti-inflammatory Drugs for Dental Product Portfolio
  54. 8.9.5 Septodont Recent Developments
  55. 8.10 PerioChip
  56. 8.10.1 PerioChip Company Information
  57. 8.10.2 PerioChip Business Overview
  58. 8.10.3 PerioChip Anti-inflammatory Drugs for Dental Revenue and Gross Margin (2021-2026)
  59. 8.10.4 PerioChip Anti-inflammatory Drugs for Dental Product Portfolio
  60. 8.10.5 PerioChip Recent Developments
  61. 8.11 Mediwin Pharmaceuticals
  62. 8.11.1 Mediwin Pharmaceuticals Company Information
  63. 8.11.2 Mediwin Pharmaceuticals Business Overview
  64. 8.11.3 Mediwin Pharmaceuticals Anti-inflammatory Drugs for Dental Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Mediwin Pharmaceuticals Anti-inflammatory Drugs for Dental Product Portfolio
  66. 8.11.5 Mediwin Pharmaceuticals Recent Developments
  67. 8.12 JandJ
  68. 8.12.1 JandJ Company Information
  69. 8.12.2 JandJ Business Overview
  70. 8.12.3 JandJ Anti-inflammatory Drugs for Dental Revenue and Gross Margin (2021-2026)
  71. 8.12.4 JandJ Anti-inflammatory Drugs for Dental Product Portfolio
  72. 8.12.5 JandJ Recent Developments
  73. 8.13 GSK
  74. 8.13.1 GSK Company Information
  75. 8.13.2 GSK Business Overview
  76. 8.13.3 GSK Anti-inflammatory Drugs for Dental Revenue and Gross Margin (2021-2026)
  77. 8.13.4 GSK Anti-inflammatory Drugs for Dental Product Portfolio
  78. 8.13.5 GSK Recent Developments
  79. 8.14 DenMat
  80. 8.14.1 DenMat Company Information
  81. 8.14.2 DenMat Business Overview
  82. 8.14.3 DenMat Anti-inflammatory Drugs for Dental Revenue and Gross Margin (2021-2026)
  83. 8.14.4 DenMat Anti-inflammatory Drugs for Dental Product Portfolio
  84. 8.14.5 DenMat Recent Developments
  85. 8.15 Colgate-Palmolive
  86. 8.15.1 Colgate-Palmolive Company Information
  87. 8.15.2 Colgate-Palmolive Business Overview
  88. 8.15.3 Colgate-Palmolive Anti-inflammatory Drugs for Dental Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Colgate-Palmolive Anti-inflammatory Drugs for Dental Product Portfolio
  90. 8.15.5 Colgate-Palmolive Recent Developments
  91. 8.16 Bausch Health
  92. 8.16.1 Bausch Health Company Information
  93. 8.16.2 Bausch Health Business Overview
  94. 8.16.3 Bausch Health Anti-inflammatory Drugs for Dental Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Bausch Health Anti-inflammatory Drugs for Dental Product Portfolio
  96. 8.16.5 Bausch Health Recent Developments
  97. 8.17 Acteon
  98. 8.17.1 Acteon Company Information
  99. 8.17.2 Acteon Business Overview
  100. 8.17.3 Acteon Anti-inflammatory Drugs for Dental Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Acteon Anti-inflammatory Drugs for Dental Product Portfolio
  102. 8.17.5 Acteon Recent Developments
  103. 8.18 3M
  104. 8.18.1 3M Company Information
  105. 8.18.2 3M Business Overview
  106. 8.18.3 3M Anti-inflammatory Drugs for Dental Revenue and Gross Margin (2021-2026)
  107. 8.18.4 3M Anti-inflammatory Drugs for Dental Product Portfolio
  108. 8.18.5 3M Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst